亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes

医学 新辅助治疗 肿瘤科 放化疗 放射治疗 结直肠癌 内科学 外科肿瘤学 荟萃分析 化疗 外科 癌症 乳腺癌
作者
Joseph C. Kong,Mikael L. Soucisse,Michael Michael,Jeanne Tie,Samuel Y. Ngan,Trevor Leong,Jacob McCormick,Satish K. Warrier,Alexander G. Heriot
出处
期刊:Annals of Surgical Oncology [Springer Science+Business Media]
卷期号:28 (12): 7476-7486 被引量:60
标识
DOI:10.1245/s10434-021-09837-8
摘要

Total neoadjuvant therapy in rectal cancer refers to the administration of chemoradiotherapy plus chemotherapy before surgery. Recent studies have shown improved pathological complete response and disease-free survival with this approach. However, survival benefits remain unproven. Our objective is to present a metaanalysis of oncological outcomes of total neoadjuvant therapy in locally advanced rectal cancer.A comprehensive search was performed on PubMed, Medline, and Google Scholars. Studies comparing total neoadjuvant therapy with standard neoadjuvant chemoradiotherapy were included. Data extracted from the individual studies were pooled and a metaanalysis performed. The outcomes of interest are the rate of complete pathological response, nodal response, resection margin, anal preservation, anastomotic leak, local recurrence, distant recurrence, disease-free survival, and overall survival.There were 15 comparative studies with 2437 patients in the neoadjuvant chemoradiotherapy group and 2284 in the total neoadjuvant therapy group. The pooled complete pathological response was 22.3% in the total neoadjuvant therapy group, compared with 14.2% in the standard neoadjuvant chemoradiotherapy group (p < 0.001). Even though there was no difference in local recurrence rate, there was a significantly lower rate of distant recurrence (OR 0.81, p = 0.02), and better 3-year disease-free survival (70.6% vs. 65.3%, respectively, p < 0.001) and overall survival (84.9% vs. 82.3%, respectively, p = 0.006), favoring the total neoadjuvant therapy group. Due to significant heterogeneity in the study protocols, there remains uncertainty on the ideal chemotherapy/radiotherapy sequence.This study provides supporting evidence on the favorable immediate and intermediate oncological outcomes with the use of total neoadjuvant therapy for locally advanced rectal cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Boren发布了新的文献求助10
刚刚
大个应助Boren采纳,获得10
12秒前
Raunio完成签到,获得积分10
14秒前
Akitten发布了新的文献求助10
27秒前
完美世界应助lhy采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
Boren发布了新的文献求助10
1分钟前
lhy发布了新的文献求助10
1分钟前
董可以发布了新的文献求助10
1分钟前
风吹而过完成签到 ,获得积分10
1分钟前
乐乐应助董可以采纳,获得10
1分钟前
2分钟前
2分钟前
liufan完成签到 ,获得积分10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
打打应助科研通管家采纳,获得30
3分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
3分钟前
3分钟前
杪夏二八完成签到 ,获得积分10
4分钟前
souther完成签到,获得积分0
4分钟前
乐乐应助Akitten采纳,获得10
4分钟前
4分钟前
kangkang发布了新的文献求助10
4分钟前
传奇完成签到 ,获得积分10
5分钟前
jyy关闭了jyy文献求助
5分钟前
丘比特应助怕孤单的思雁采纳,获得10
5分钟前
5分钟前
5分钟前
Akitten发布了新的文献求助10
5分钟前
5分钟前
Li完成签到,获得积分10
6分钟前
6分钟前
自然的衫完成签到 ,获得积分10
6分钟前
6分钟前
阿巴阿巴茶完成签到,获得积分10
6分钟前
lhy发布了新的文献求助10
7分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990332
求助须知:如何正确求助?哪些是违规求助? 3532146
关于积分的说明 11256483
捐赠科研通 3271042
什么是DOI,文献DOI怎么找? 1805207
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234